Mirae Asset Global Investments Co., Ltd.

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1569395 SEOUL, M5

Position in TRDA

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$12,776

-$12,426 QoQ

Shares Held

1,736

-13.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#102

of 128 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. TRDA ranks #181 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,776	1,736	-13.1%	Shares	Sole	2026-07-22
2026-03-31	$25,202	1,997	+7.5%	Shares	Sole	2026-08-12
2025-12-31	$19,089	1,857	+26.2%	Shares	Sole	2026-01-26
2025-09-30	$8,531	1,471	+0.3%	Shares	Sole	2025-11-03
2025-06-30	$9,851	1,466	+16.5%	Shares	Sole	2025-07-21
2025-03-31	$11,372	1,258	+1.0%	Shares	Sole	2025-04-24
2024-12-31	$21,543	1,246	-88.5%	Shares	Sole	2025-01-27
2023-12-31	$164,088	10,874	0.0%	Shares	Defined	2024-01-24
2023-09-30	$171,809	10,874	0.0%	Shares	Defined	2023-10-26
2023-06-30	$164,632	10,874	—	Shares	Defined	2023-08-10
No filing history on record for this holder in this stock.